HIV Postexposure Prophylaxis Does Not Increase Risky Behavior

Article

WESTPORT, CT-Some scientists and researchers worried that an HIV postexposure prophylaxis (PEP) would increase high-risk behavior among its recipients. However, the results of a new study prove otherwise.

J.N. Martin, MD, of the University of California at San Francisco said there was a theoretical concern that the drugs would be an easy way for a person to protect him or herself, therefore, allowing risky behavior.

However, his team followed 400 individuals starting 4 weeks of HIV treatment within 72 hours of suspected exposure to the virus. The study, which involved mainly gay or bisexual men, showed a 74% drop in high-risk behavior after the suspected exposure. About 10% of the group reported an increase. The percentages remained almost the same after one year.

Martin pointed out that there are good reasons to avoid repeating the prescription. HIV PEP has side effects, the drugs are expensive and are not 100% effective.

The results of the study were presented at the 8th Conference on Retroviruses and Opportunistic Infections in Chicago.

Information from www.hivandhepatitis.com

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.